EP 1534310 A4 20060531 - PEPTIDES ANTIBODIES DIRECTED THEREAGAINST AND METHODS USING SAME FOR DIAGNOSING AND TREATING AMYLOID-ASSOCIATED DISEASES
Title (en)
PEPTIDES ANTIBODIES DIRECTED THEREAGAINST AND METHODS USING SAME FOR DIAGNOSING AND TREATING AMYLOID-ASSOCIATED DISEASES
Title (de)
PEPTIDE, DAGEGEN GERICHTETE ANTIKÖRPER UND VERFAHREN ZU IHRER VERWENDUNG FÜR DIE DIAGNOSE UND BEHANDLUNG VON ERKRANKUNGEN IN ZUSAMMENHANG MIT AMYLOID
Title (fr)
PEPTIDES, ANTICORPS DIRIGES CONTRE LES MALADIES ASSOCIEES A L'AMYLOIDE ET PROCEDES UTILISANT CES PEPTIDES ET CES ANTICORPS EN VUE DE DIAGNOSTIQUER ET DE TRAITER CES MALADIES
Publication
Application
Priority
- IL 0300079 W 20030130
- US 35257802 P 20020131
- US 39226602 P 20020701
- US 23585202 A 20020906
- US 43645302 P 20021227
Abstract (en)
[origin: WO03063760A2] A peptide comprising at least 3 amino acid residues and less than 15 amino acid residues, the peptide including an amino acid sequence as set forth in SEQ ID NO: 7 as well as pharmaceutical compositions and kits including same, and methods using same for diagnosing and treating amyloid associated diseases.
IPC 1-7
C07K 14/47; C07K 14/575; C07K 14/585; C07K 5/103; C07K 5/107; C07K 5/113; C07K 5/093; C07K 16/18; C07K 16/26; A61K 38/06; A61K 38/07; A61K 38/17; A61K 38/22; A61K 38/23; A61K 39/395; A61P 25/28
IPC 8 full level
A61P 25/28 (2006.01); C07K 5/093 (2006.01); C07K 5/103 (2006.01); C07K 5/107 (2006.01); C07K 5/113 (2006.01); C07K 14/47 (2006.01); C07K 14/575 (2006.01); C07K 14/585 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP KR)
A61P 3/10 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07K 5/0819 (2013.01 - EP); C07K 5/1008 (2013.01 - EP); C07K 5/1016 (2013.01 - EP); C07K 5/1021 (2013.01 - EP); C07K 7/00 (2013.01 - KR); C07K 7/04 (2013.01 - KR); C07K 14/00 (2013.01 - KR); C07K 14/4711 (2013.01 - EP); C07K 14/575 (2013.01 - EP); C07K 14/585 (2013.01 - EP)
Citation (search report)
- [X] WO 9820135 A2 19980514 - US GOV HEALTH & HUMAN SERV [US], et al
- [X] US 5659041 A 19970819 - POLLAK ALFRED [CA], et al
- [X] DATABASE WPI Section Ch Week 200054, Derwent World Patents Index; Class B04, AN 2000-574422, XP002373536
- [X] DATABASE WPI Section Ch Week 198814, Derwent World Patents Index; Class B04, AN 1988-094820, XP002373539 & DATABASE Geneseq [online] 22 December 2000 (2000-12-22), "Human amyloid A2-beta N-terminal peptide.", XP002373534, retrieved from EBI accession no. GSP:AAB22782 Database accession no. AAB22782
- See references of WO 03063760A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
DOCDB simple family (publication)
WO 03063760 A2 20030807; WO 03063760 A3 20050210; AU 2003207973 A1 20030902; CA 2473987 A1 20030807; CA 2473987 C 20131119; EP 1534310 A2 20050601; EP 1534310 A4 20060531; JP 2006506942 A 20060302; KR 20040081165 A 20040920
DOCDB simple family (application)
IL 0300079 W 20030130; AU 2003207973 A 20030130; CA 2473987 A 20030130; EP 03704977 A 20030130; JP 2003563456 A 20030130; KR 20047011868 A 20030130